Protein kinase C-β inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats

Experimental and Therapeutic Medicine
Guang-Xing MengYi-Jun Wang

Abstract

Hepatic ischemia and reperfusion (I/R) injury plays an active role in hepatic resection and transplantation. While the effects of protein kinase C (PKC)-βII activation and the role of PKC-β inhibitors are well understood in myocardial I/R in diabetes, they remain unclear in liver I/R. The aim of this study was to explore the effect of PKC-β inhibition and the potential mechanism by which PKC-β inhibitor treatment protects against hepatic I/R injury in diabetic rats. Diabetic rats were established and randomized into two groups. These were an untreated group (n=10), which did not receive any treatment, and a treatment group (n=10), orally treated with ruboxistaurin at a dose of 5 mg/kg/day for 2 weeks. The rats from the two groups were subjected to hepatic I/R. Aspartate transaminase (AST) and lactate dehydrogenase (LDH) levels were measured by enzymatic methods at 1, 3 and 5 h after I/R. Tumor necrosis factor-α (TNF-α) and intercellular adhesion molecule 1 (ICAM-1) were examined by enzyme-linked immunosorbent assay at the same time-points. Nuclear factor-κB (NF-κB) p65 expression was analyzed by immunofluorescence and western blotting. Apoptosis of hepatic cells was examined by the western blot analysis of caspase 3 expression ...Continue Reading

References

Jul 16, 2003·Journal of Gastroenterology and Hepatology·Narci C Teoh, Geoffrey C Farrell
Sep 17, 2003·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jun XuJinhua Zeng
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pierre-Michel HuetMarc Bilodeau
Nov 15, 2006·Molecular and Cellular Biology·Xiaoyun ChenXiao-Ming Yin
Aug 25, 2007·Journal of Gastroenterology and Hepatology·Etsuro Hatano
Dec 7, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Margaret Clarke, Paul M Dodson
May 30, 2008·American Journal of Physiology. Cell Physiology·Elizabeth GallowayAlex B Lentsch
Jan 2, 2010·Apoptosis : an International Journal on Programmed Cell Death·Liping WeiHaichang Wang
May 1, 2010·Circulation Research·Pedro Geraldes, George L King
Jun 3, 2010·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Li-Ming JinShu-Sen Zheng
Dec 9, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juliette MartinJean-François Dufour
Dec 25, 2010·World Journal of Gastroenterology : WJG·Rene Schmidt
Nov 22, 2011·Clinics and Research in Hepatology and Gastroenterology·An Ping SuTao Hu
Aug 21, 2013·Transplantation Proceedings·J YangK A Candiotti
Jul 19, 2014·The Journal of Surgical Research·Theodore KaratzasIsmene A Dontas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.